Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis

被引:0
|
作者
Gately, S
Kerbel, R
机构
[1] NeoPharm Inc, Dept Translat Med, Lake Forest, IL 60045 USA
[2] Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:179 / 192
页数:14
相关论文
共 50 条
  • [21] Proapoptotic and anti proliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells
    Kern, MA
    Schubert, D
    Sahi, D
    Schöneweiss, MM
    Moll, I
    Haugg, AM
    Dienes, HP
    Breuhahn, K
    Schirmacher, P
    HEPATOLOGY, 2002, 36 (04) : 885 - 894
  • [22] Thalidomide, cyclooxygenase-2, and angiogenesis: Potential for therapy
    Onn, A
    Tseng, JE
    Herbst, RS
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3311 - 3313
  • [23] Selective inhibitors of cyclooxygenase-2: new perspectives of human diseases management
    Nasonov, EL
    Tsvetkova, ES
    Tov, NL
    TERAPEVTICHESKII ARKHIV, 1998, 70 (05) : 8 - 14
  • [24] Selective Cyclooxygenase-2 Inhibitors: Design and Synthesis
    Xin Sheng LEI
    Zong Ru GUO
    Ling Bo QU
    Qi Qing ZHU(Institute of Materia Medica. Chinese Academy of Medical SciencesAnd Peking Union Medical College. Beijing 100050)
    Chinese Chemical Letters, 1999, (06) : 469 - 472
  • [25] Renal effects of cyclooxygenase-2 selective inhibitors
    Harris, CJ
    Brater, DC
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (05): : 603 - 610
  • [26] Selective cyclooxygenase-2 inhibitors: Design and synthesis
    Lei, XS
    Guo, ZR
    Qu, LB
    Zhu, QQ
    CHINESE CHEMICAL LETTERS, 1999, 10 (06) : 469 - 472
  • [27] Selective cyclooxygenase-2 inhibitors: hope and facts
    Berenbaum, F
    JOINT BONE SPINE, 2000, 67 (06) : 499 - 501
  • [28] Selective cyclooxygenase-2 inhibitors: similarities and differences
    Brune, K
    Hinz, B
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (01) : 1 - 6
  • [29] Selective cyclooxygenase-2 inhibitors for the treatment of arthritis
    Fung, HB
    Kirschenbaum, HL
    CLINICAL THERAPEUTICS, 1999, 21 (07) : 1131 - 1157
  • [30] Cardiovascular risk of selective cyclooxygenase-2 inhibitors
    Schrör, K
    Mehta, P
    Mehta, JL
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2005, 10 (02) : 95 - 101